We have previously reported that the responsiveness of blood pressure to nitrendipine, a dihydropyridine calcium antagonist, varies with its time of adminis tration. The present study was undertaken to examine whether the diuretic effects of the agent also show diurnal variation. There is increasing evidence demonstrating time-dependent changes in the effectiveness of cardiovascular agents (1). We already examined the chronopharmacological profiles of nitrendipine, a dihydropyridine calcium antagonist. This study demonstrated that the responsiveness of blood pressure to the agent varies with its administration time (2).
There is increasing evidence demonstrating time-dependent changes in the effectiveness of cardiovascular agents (1) . We already examined the chronopharmacological profiles of nitrendipine, a dihydropyridine calcium antagonist. This study demonstrated that the responsiveness of blood pressure to the agent varies with its administration time (2) .
Nitrendipine is frequently used in the treat ment of hypertension and the related car diovascular diseases. Unlike other vasodilators such as hydralazine, prazosin and minoxidil, calcium antagonists are not associated with water and sodium retention, but cause a mild diuresis and natriuresis following, at least, the first dosage (3, 4) . This pharmacological prop erty of calcium antagonists may be involved in the mechanism responsible for their anti hypertensive action. Therefore, it is interesting to examine whether the diuretic effects of nit rendipine also show diurnal variations.
In the present study, nitrendipine was given orally at 12 a.m. or 12 p.m. to rats. The diure tic effects following the agent at 12 a.m. were compared to those when it was given at 12 p.m.
Male Wistar rats (Charles River Laboratory, Kanagawa, Japan) (10-11 weeks old, 300 350 g) were maintained for more than 2 weeks under conditions of light from 7 a.m. to 7 p.m. and dark from 7 p.m. to 7 a.m. with free access to food and water.
Since a diuretic effect following a high dose of a calcium antagonist might be masked by a concomitant reduction in blood pressure (5), the first experiment was performed to deter mine the optimal dosage of nitrendipine for the subsequent study. Rats were randomly divided into two groups. The first group of rats (group I, n = 16) received nitrendipine at 12 a.m., while the second group of animals (group II, n = 16) received the agent at 12 p.m. Three percent body weight (b.w.) of 1% NaCI solution was given orally to each group of rats on day 1. Nitrendipine (Yoshitomi Pharmaceutical Industries, Ltd., Osaka, Japan) (0.5, 2.0 and 10.0 mg/kg in 3% b.w. of 1 % NaCl) was given orally to each group of rats on day 4, 7 and 10, respectively. Urine was collected for 8 hours following vehicle alone or the drug administration. The animals were deprived of food and water for 8 hours following each administration.
Since the 2.0 mg/kg of nitrendipine was judged as the optimal dosage, this dosage was used for the subsequent experiment. Twenty eight rats were used in the second experiment. Three percent b.w. of 1% NaCI solution was given orally at 12 a.m. (or 12 p.m.). Twenty four hours after the vehicle alone, 2.0 mg/kg of nitrendipine in 3% b.w. of vehicle was given orally at 12 a.m. (or 12 p.m.). Urine was collected for 8 hours after each administration. The experiment timing was randomly assigned to 12 a.m. or 12 p.m. The washout period between the two sets of experiments was 2.5 days.
Urinary sodium concentration was deter mined by flame photometry (Flame Photom eter 775-A, Hitachi, Tokyo, Japan).
The results are expressed as the mean ± S.E. Data were analyzed by analysis of variance and the Wholly-Significant-Difference Method.
First experiment (Table 1) : Urine volume and urinary sodium excretion increased dose dependently following 0.5 and 2.0 mg/kg of nitrendipine in both trials. However, these diuretic effects of the agent were slightly reduced by a dose of 10.0 mg/kg.
Second experiment (Fig. 1) : When 3% b.w. of NaCI solution was given as a nitrendipine control, no significant difference was observed in urine volume or urinary sodium excretion in the collection period following the 12 a.m. administration (day trial: urine volume, 20.7 ± 0.9 ml/kg/8 hr; urinary sodium, 3.4 ± 0.1 mEq/kg/8 hr) compared to the collection period beginning at 12 p.m. (night trial: urine volume, 19.9 ± 1.1 ml/kg/8 hr; urinary sodium, 3.7 ± 0.2 mEq/kg/8 hr). Urine volume and urinary sodium excretion increased after 2.0 mg/kg of nitrendipine in the day (urine volume, 24.8 ± 1.0 ml/kg/8 hr; urinary sodium, 4.0 ± 0.2 mEq/kg/8 hr) and night (urine volume, 28.0 ± 1.0 ml/kg/8 hr; urinary sodium, 5.0 ± 0.1 mEq/kg/8 hr) trials. These param eters following the agent were significantly greater at 12 p.m. than at 12 a.m. It is known that a decrease in blood pres sure in itself exerts an antinatriuretic effect (6). Thus, a relatively small dose of nitrendi pine, which might not cause a large reduction in blood pressure, must be employed when the diuretic profiles of the agent are examined. Previous studies using normotensive Wistar rats (7) have demonstrated that the mean reductions in blood pressure following 1.0 and 3.1 mg/kg of nitrendipine were small (4 mmHg: 114 110 mmHg, and 7 mmHg: 119 112 mmHg, respectively) while the reduc tion after 10.0 mg/kg of the agent was large (22 mmHg: 117 95 mmHg). These data indi cate that the diuretic effects of 10.0 mg/kg of nitrendipine may be partly offset by a concomi tant hemodynamic change. In fact, the present study showed that the pharmacological effects of nitrendipine are blunted at the higher dose (10.0 mg/kg). On the other hand, its diuretic effects were small at a dose of 0.5 mg/kg. Therefore, 2.0 mg/kg of nitrendipine was used for the subsequent chronopharmacological study.
Our previous studies have demonstrated that the responsiveness of blood pressure to nitrendipine after the morning dose is greater than that after the evening dosage in human subjects (2) . The present study was under taken to extent this chronopharmacological observation to other pharmacological effects of nitrendipine in saline loaded rats. The pres ent study showed that the diuretic and natri uretic effects of nitrendipine are greater when it is administered at 12 p.m. corresponding to the rat's awake period than when it is adminis tered at 12 a.m. which is their sleep period. Based on these findings, it is antici pated that the cardiovascular as well as renal effects of nitrendipine vary with its time of administration.
Nitrendipine inhibits directly proximal sodium and water reabsorption (8, 9) whose mechanisms are still unknown. In addition, saline loading itself causes a mild diuresis and natriuresis by a multifactorial mechanism involving renal, hormonal and physical factors (10 12) . Therefore, the enhanced renal re sponse following nitrendipine is likely to be the results of the direct renal tubular effect modified by its effect on the mechanisms involved in the saline-induced diuresis.
The potential mechanisms by which the renal response to nitrendipine shows diurnal variation are as follows: 1) The plasma con centration of nitrendipine varies with its time of dosing. Temporal variation of plasma con centration of the agent has already been documented (2) . 2) The susceptibility of renal tissues to nitrendipine shows diurnal changes. A similar chronopharmacological property has also been reported for trichlormethiazide (13) . Finally, renal and hormonal functions involved in the regulation of water and electrolyte homeostasis exhibit circadian changes (14, 15) , and consequently influence the renal effects of nitrendipine.
The present study is unable to rule out any of these possibilities, and further studies are needed to evaluate them.
